Document Classification

Section Type: RESULTS

Text: Compared with the control group, 12-week treatment with E/D or CEE/MPA reduced fibrinogen (-7. 7 %, p = 0. 004 and -3. 3 %, p = 0. 083, respectively), factor VII-act (-8. 7 %, p = 0. 14 and -9. 7 %, p = 0. 06, respectively), homocysteine (-20. 5 %, p = 0. 02 and -26. 7 %, p = 0. 005, respectively), and IGF-1 (-27. 9 %, p < 0. 001 and -18. 1 %, p = 0. 002, respectively), but increased factor VII-ag (+10. 1 %, p = 0. 03 and +4. 4 %, p = 0. 46, respectively), endothelin-1 (+15. 2 %, p = 0. 12 and +20. 0 %, p = 0. 13, respectively) and C-reactive protein (+88. 8 %, p = 0. 18 and +71. 0 %, p = 0. 44, respectively).